Role of MRI in Diagnosis of Postmenopausal Bleeding Causes
Role of MRI in Diagnosis of Causes of Postmenopausal Bleeding in Correlation to Histopathological Results
1 other identifier
observational
36
0 countries
N/A
Brief Summary
The aim of the study is to determine the diagnostic performance of MRI of endometrial pathology in postmenopausal women with postmenopausal bleeding
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2023
CompletedFirst Posted
Study publicly available on registry
August 22, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedAugust 22, 2023
August 1, 2023
1 year
August 15, 2023
August 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
comparison between pre-biopsy MRI based diagnosis and histopathological proved diagnosis in cases of post-menopausal vaginal bleeding
anaylsis between pre-biopsy MRI based diagnosis and histopathological proved diagnosis in cases of post-menopausal vaginal bleeding
baseline
Interventions
a type of scan that uses strong magnetic field sand radio waves to produce detailed images of the inside of the body
Eligibility Criteria
Any female patient after menopause suffering from vaginal bleeding
You may qualify if:
- Any female patient after menopause suffering from vaginal bleeding.
- Patients receiving tamoxifen with vaginal bleeding.
- Patient had histopathological biopsy examination either by total hysterectomy, hysteroscopy or D \&C.
- Patient must have local cause
You may not qualify if:
- \. Patients not amenable for MRI examination 2. Patients not in menopause 3. Patients have general bleeding tendency 4. Patients not underwent histopathological biopsy examination
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Dubinsky TJ, Parvey HR, Maklad N. The role of transvaginal sonography and endometrial biopsy in the evaluation of peri- and postmenopausal bleeding. AJR Am J Roentgenol. 1997 Jul;169(1):145-9. doi: 10.2214/ajr.169.1.9207515.
PMID: 9207515BACKGROUNDKarlsson B, Granberg S, Wikland M, Ylostalo P, Torvid K, Marsal K, Valentin L. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding--a Nordic multicenter study. Am J Obstet Gynecol. 1995 May;172(5):1488-94. doi: 10.1016/0002-9378(95)90483-2.
PMID: 7755059BACKGROUNDGull B, Karlsson B, Milsom I, Granberg S. Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol. 2003 Feb;188(2):401-8. doi: 10.1067/mob.2003.154.
PMID: 12592247BACKGROUNDFoti PV, Tonolini M, Costanzo V, Mammino L, Palmucci S, Cianci A, Ettorre GC, Basile A. Cross-sectional imaging of acute gynaecologic disorders: CT and MRI findings with differential diagnosis-part II: uterine emergencies and pelvic inflammatory disease. Insights Imaging. 2019 Dec 20;10(1):118. doi: 10.1186/s13244-019-0807-6.
PMID: 31858287BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hossam ElDen Mustafa Kamel, MD
unaffilitated
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer
Study Record Dates
First Submitted
August 15, 2023
First Posted
August 22, 2023
Study Start
October 1, 2023
Primary Completion
October 1, 2024
Study Completion
November 1, 2024
Last Updated
August 22, 2023
Record last verified: 2023-08